Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
Liu, Xinxue Munro, Alasdair Ps Feng, Shuo Janani, Leila Aley, Parvinder K Babbage, Gavin Baxter, David Bula, Marcin Cathie, Katrina Chatterjee, Krishna
Liu, Xinxue
Munro, Alasdair Ps
Feng, Shuo
Janani, Leila
Aley, Parvinder K
Babbage, Gavin
Baxter, David
Bula, Marcin
Cathie, Katrina
Chatterjee, Krishna
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2023-04-12
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Liu X, Munro AP, Feng S, Janani L, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dejnirattisai W, Dodd K, Enever Y, Qureshi E, Goodman AL, Green CA, Harndahl L, Haughney J, Hicks A, van der Klaauw AA, Kwok J, Libri V, Llewelyn MJ, McGregor AC, Minassian AM, Moore P, Mughal M, Mujadidi YF, Holliday K, Osanlou O, Osanlou R, Owens DR, Pacurar M, Palfreeman A, Pan D, Rampling T, Regan K, Saich S, Serafimova T, Saralaya D, Screaton GR, Sharma S, Sheridan R, Sturdy A, Supasa P, Thomson EC, Todd S, Twelves C, Read RC, Charlton S, Hallis B, Ramsay M, Andrews N, Lambe T, Nguyen-Van-Tam JS, Cornelius V, Snape MD, Faust SN; COV-BOOST study group. Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]. J Infect. 2023 May;86(5):540-541. doi: 10.1016/j.jinf.2023.03.025. Epub 2023 Apr 12. Erratum for: J Infect. 2022 Jun;84(6):795-813
Type
Article